Economic Considerations for the Treatment of Opioid and Alcohol Dependence

home / publications / supplement / a369_june11

Cost and Utilization Outcomes of Opioid-Dependence Treatments

Onur Baser, MS, PhD;Mady Chalk, PhD;David A. Fiellin, MD;David R. Gastfriend, MD

ArticleARTICLES

Alcohol Dependence Treatments: Comprehensive Healthcare Costs, Utilization Outcomes, and Pharmacotherapy Persistence

Onur Baser, MS, PhD;Mady Chalk, PhD;Richard Rawson, PhD;David R. Gastfriend, MD

ArticleARTICLES

Extended-Release Naltrexone for Alcohol Dependence: Persistence and Healthcare Costs and Utilization

William C. Bryson, MD, MPH;K. John McConnell, PhD;P. Todd Korthuis, MD, MPH;Dennis McCarty, PhD

ArticleARTICLES

Utilization Patterns of Extended-Release Naltrexone for Alcohol Dependence

Saira Jan, PharmD;Patrick Gill, RPh;Ami S. Borawala, PharmD

ArticleARTICLES

Economic Considerations for the Treatment of Opioid and Alcohol Dependence: A Managed Care Perspective

Jeffrey D. Dunn, PharmD, MBA, Formulary;Contract Manager, SelectHealth

ArticleARTICLES

Participating Faculty: Economic Considerations for the Treatment of Opioid and Alcohol Dependence

ArticleAUTHOR INDEX

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions